Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 11, 2021 10:28am
76 Views
Post# 33371725

RE:RE:Price targets without piper

RE:RE:Price targets without piperSorry Stups, I only need one ID.  Show me any post where I said FDA would never approve or plant not inspected.  You can't do it.

As usual when your predictions fail you move the goal posts.  Now its after we get the cash from the voucher that will be sold "next days".

Also, here is today's information from that link you like to yap about.  Your posting is 4-6 months old because you like to show a higher price.  Here is TODAY'S INFORMATION AND RECOMMENDATION.

HOLD....not buy....Who is the clown now you doofus.  Post current information and stop trying to deceive people.

LMNL Analyst Ratings

CONSENSUSHold

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

  • BLOOM BURTON&CO
  • H C WAINWRIGHT
  • LEEDE JONES GAB
  • PIPER SANDLER

Analyst

$7.75

Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $7.75 with a high estimate of $11 and a low estimate of $4.5.






realstocky wrote:

and these are the price targets without piper that issued a price target couple days BEFORE the FDA ok for riplazym (why not wait...$), nul and void, we're already trading above it... Gunner is a clown, the sp will 2x,3x,4x upon  cashing the 100M$ from the riplazym voucher, it will be sold next days. He also said FDA would never give the ok, plant not inspected by FDA blablabla he is a basher/spammer just like plitheone (probably same genius).

All these people telling u to sell are only here for a rea$on... it's accumulation time..market cap only 140M$, when it runs it will explode up.

 

Newcamo wrote:

 

https://www.marketbeat.com/stocks/NASDAQ/LMNL/price-target/

 

LMNL Consensus Rating: Hold Hold Hold Hold
LMNL Consensus Rating Score: 2.20 2.25 2.33 2.00
LMNL Analyst Ratings: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
LMNL Consensus Price Target: $18.00 $18.00 $21.50 $21.00
LMNL Price Target Upside: 333.73% upside 283.39% upside 425.67% upside N/A

 

-----------------------------

average price target moved from 11$ to 16,50$;) Buy low, sell high...

LMNL Analyst Research

LMNL Analyst Ratings

Consensus Buy

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

  • BLOOM BURTON&CO
  • H C WAINWRIGHT
  • LEEDE JONES GAB
  • PIPER SANDLER

Analyst

$16.5

Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $16.5 with a high estimate of $22 and a low estimate of $11. Sign in to your SmartPortfolio to see more analyst recommendations.

 

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research




<< Previous
Bullboard Posts
Next >>